Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Interpreting the Epstein-Barr Virus (EBV) epigenome using high-throughput data.

Arvey A, Tempera I, Lieberman PM.

Viruses. 2013 Apr 2;5(4):1042-54. doi: 10.3390/v5041042. Review.

2.

An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions.

Arvey A, Tempera I, Tsai K, Chen HS, Tikhmyanova N, Klichinsky M, Leslie C, Lieberman PM.

Cell Host Microbe. 2012 Aug 16;12(2):233-45. doi: 10.1016/j.chom.2012.06.008.

3.

BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression.

Woellmer A, Arteaga-Salas JM, Hammerschmidt W.

PLoS Pathog. 2012 Sep;8(9):e1002902. doi: 10.1371/journal.ppat.1002902. Epub 2012 Sep 6.

4.

Genome-wide DNA methylation as an epigenetic consequence of Epstein-Barr virus infection of immortalized keratinocytes.

Birdwell CE, Queen KJ, Kilgore PC, Rollyson P, Trutschl M, Cvek U, Scott RS.

J Virol. 2014 Oct;88(19):11442-58. doi: 10.1128/JVI.00972-14. Epub 2014 Jul 23.

5.

Epigenetic regulation of EBV persistence and oncogenesis.

Tempera I, Lieberman PM.

Semin Cancer Biol. 2014 Jun;26:22-9. doi: 10.1016/j.semcancer.2014.01.003. Epub 2014 Jan 24. Review.

6.

CTCF prevents the epigenetic drift of EBV latency promoter Qp.

Tempera I, Wiedmer A, Dheekollu J, Lieberman PM.

PLoS Pathog. 2010 Aug 12;6(8):e1001048. doi: 10.1371/journal.ppat.1001048.

7.

Role of epigenetics in EBV regulation and pathogenesis.

Niller HH, Tarnai Z, Decsi G, Zsedényi A, Bánáti F, Minarovits J.

Future Microbiol. 2014;9(6):747-56. doi: 10.2217/fmb.14.41. Review.

PMID:
25046522
8.

Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.

Tempera I, De Leo A, Kossenkov AV, Cesaroni M, Song H, Dawany N, Showe L, Lu F, Wikramasinghe P, Lieberman PM.

J Virol. 2015 Oct 14;90(1):345-55. doi: 10.1128/JVI.02318-15.

9.

Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.

Wolf J, Pawlita M, Klevenz B, Frech B, Freese UK, Müller-Lantzsch N, Diehl V, zur Hausen H.

Int J Cancer. 1993 Feb 20;53(4):621-7.

PMID:
8382194
10.

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.

Niller HH, Wolf H, Minarovits J.

Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Review.

PMID:
18432410
12.

AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome.

Kalla M, Schmeinck A, Bergbauer M, Pich D, Hammerschmidt W.

Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):850-5. doi: 10.1073/pnas.0911948107. Epub 2009 Dec 22.

13.

Host genetic variants and gene expression patterns associated with Epstein-Barr virus copy number in lymphoblastoid cell lines.

Houldcroft CJ, Petrova V, Liu JZ, Frampton D, Anderson CA, Gall A, Kellam P.

PLoS One. 2014 Oct 7;9(10):e108384. doi: 10.1371/journal.pone.0108384. eCollection 2014.

14.

Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.

Niller HH, Wolf H, Minarovits J.

Semin Cancer Biol. 2009 Jun;19(3):158-64. doi: 10.1016/j.semcancer.2009.02.012. Epub 2009 Feb 24. Review.

PMID:
19429479
15.

High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.

Bakos A, Banati F, Koroknai A, Takacs M, Salamon D, Minarovits-Kormuta S, Schwarzmann F, Wolf H, Niller HH, Minarovits J.

Virus Genes. 2007 Oct;35(2):195-202. Epub 2007 May 18.

PMID:
17510783
16.

The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.

Lear AL, Rowe M, Kurilla MG, Lee S, Henderson S, Kieff E, Rickinson AB.

J Virol. 1992 Dec;66(12):7461-8.

17.
18.

Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1,000 Genomes Project.

Santpere G, Darre F, Blanco S, Alcami A, Villoslada P, Mar Albà M, Navarro A.

Genome Biol Evol. 2014 Apr;6(4):846-60. doi: 10.1093/gbe/evu054.

19.
20.

Complementation between infecting Epstein-Barr virus and intrinsic viral genomes in human lymphoid cell lines.

Lidin BI, Lamon EW, Cloud G, Soong SJ.

Intervirology. 1982;18(1-2):66-75.

PMID:
6288617

Supplemental Content

Support Center